Skip to main content
Cristina Cusin, MD, Psychiatry, Boston, MA

Cristina Cusin MD

Psychiatry•Boston, MA

Director of Translational Studies in Depression at Massachuseets General Hospital. Assistant Professor in Psychiatry at Harvard Medical School.

Join to view full profile

  • 101 Nicolls RdBoston, MA 11794

  • Phone+1 617-726-2066

Dr. Cusin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Cusin's full profileAlready have an account?

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/McLean Hospital
    Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 2006 - 2010
  • University of Milan Faculty of Medicine
    University of Milan Faculty of MedicineClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2028
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)  
    Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature

Press Mentions

  • Ketamine for Suicidality: Evidence on Rapid Effects, Mechanisms, and Clinical Considerations
    Ketamine for Suicidality: Evidence on Rapid Effects, Mechanisms, and Clinical ConsiderationsOctober 10th, 2025
  • Ketamine Derivative OK’d by FDA Can Be a Wonder Drug for Some. Insurers Still Have to Catch Up
    Ketamine Derivative OK’d by FDA Can Be a Wonder Drug for Some. Insurers Still Have to Catch UpFebruary 24th, 2025
  • Atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment
    Atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine TreatmentNovember 17th, 2022

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Cristina Cusin, Dr. Cristina Cusin, MD, Dr. C Cusin